Epidemiology and socioeconomics of spondyloarthropathies;Epidemiologie und versorgung im bereich der spondylarthropathien

Zeitschrift fur Rheumatologie

Volumn 61, Issue 1, 2002, Pages 30-38

  Haibel, H ^a   Rudwaleit, M ^a   Braun, J ^a   Sieper, J ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Early diagnosis; Epidemiology; New therapies; Socioeconomics; Spondyloarthropathies

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; ETANERCEPT; HLA B7 ANTIGEN; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSING SPONDYLITIS; EARLY DIAGNOSIS; GERMANY; HUMAN; NETHERLANDS; REVIEW; SACROILIITIS; SOCIOECONOMICS; SPONDYLOARTHROPATHY;

ADOLESCENT; ADULT; AGED; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT CARE TEAM; SPONDYLITIS, ANKYLOSING;

EID: 0036183478     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930200004     Document Type: Review

References (36)

1. Clinical investigation of methotrexate in the treatment of ankylosing spondylitis
2. Criteria of the classification of spondylarthropathies
3. Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trial
4. CT-guided intraarticular corticosteroid injection into the sacroiliac joints in patients with spondyloarthropathy: Indication and follow-up with contrast-enhanced MRI
5. Employment, work disability, and work days lost in patients with ankylosing spondylitis: A cross sectional study of Dutch patients
6. Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: Many, but not all patients with sacroiliitis have spondyloarthropathy
7. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
8. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients
9. Treatment of active ankylosing spondylitis with infliximab - A double-blind placebo controlled multicenter trial
10. Ankyslosing Spondylitis: For given radiological involvement, who suffers more - Men or women?
11. Ankylosing Spondylitis in the Mexican mestizo: Patterns of disease according to age at onset
12. Clinical history as a screening test for ankylosing spondylitis
13. Comparison of sulphasalazine and placebo in the treatment of ankylosing spondylitis
14. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
15. Sulphasalazine in the treatment of spondylarthropathies
16. Age at disease onset and delayed diagnosis of spondyloarthropathies
17. A randomised, double-blind placebo-controlled trial of etanercept (Enbrel®) in the treatment of anykylosing spondylitis
18. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway
19. A worldwide overview: The epidemiology of HLA-B27 and associated spondylarthritides
20. Course of disease, and treatment of the spondyloarthropathies
21. An open study of pamidronate in the treatment of refractory ankylosing spondylitis
22. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy
23. Evaluation of early diagnostic criteria for ankylosing spondylitis in a 10 year follow-up
24. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year follow-up
25. HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27, B44
26. Methotrexate in severe ankylosing spondylitis: A randomised placebo controlled, double-blind observer study
27. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France
28. Inflammatory back pain in primary care
29. Iliosacral arthritis and Bechterew's ankylosing spondylitis: Early detection and therapy
30. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: A family and population study
31. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population
32. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: A randomised controlled trial
33. Functional disability predicts total medical costs in patients with ankylosing spondylitis
34. Risk factors for work disability in patients with ankylosing spondylitis
35. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - Results from the German rheumatological database
36. Epidemiological and public health aspects of inflammatory rheumatic systemic diseases